Order of the National Green Tribunal in the matter of News Item titled "2 killed in blast at illegal cracker unit in Thanjavur appearing in The Hindu dated 19.05.2025". The application is registered suo-motu on the basis of the news item titled 2 killed in blast at illegal cracker unit …
DRUG firm Glenmark Pharmaceuticals on Monday said it has achieved positive results in human trials for its new drug molecule Crofelemer, which is aimed at treating diarrhoea in adults. In a filing to the Bombay Stock Exchange (BSE), the firm said resolution of diarrhoea was significantly higher in human subjects, …
Govt Body Has Shortlisted 11 Chinese & 2 Italian Manufacturing Units For Inspection New Delhi: Chinese and Italian drug manufacturing units, from where drugs are imported into India in bulk, are now under the scanner. After several import licences of local agents of such overseas units were cancelled due to …
DRUG maker Venus Remedies on Wednesday said it has received UK health regulator's approval to market 'Gemcitabine', used in treating cancer, in the UK market. The Chandigarh-based firm has got the approval from Medicine and Healthcare Regulatory Agency (MHRA), UK for Gemcitabine in two strengths of 200 mg and 1,000 …
A recent shift in the drug product environment for Africa has seen a score of new products being developed specifically for diseases of the developing world, creating new challenges for regulators in Africa and elsewhere. However, it is not at all certain that African regulatory authorities currently have the capacity …
This is set to become a landmark case for the Indian pharmaceutical industry—and for patients. When Natco Pharma of Hyderabad wrote to Pfizer, the world’s largest drugs manufacturer, that it wanted a voluntary licence (VL) to make a low-cost version of its antiretroviral drug maraviroc, it was setting the stage …
Already banned in developed nations after it was found to be causing adverse health effects, the analgesic nimesulide may now be suspended from paediatric use in India too. The Drug Controller General of India (DCGI) Dr Surinder Singh will take a final call on the fate of the drug on …
First the good news: the year 2010 saw for the first time the Rs 52,271-crore Indian drug market throw up a Rs 200-crore plus brand. However, this comes with a bitter pill
The largest drug firm of Japan, Takeda Pharmaceuticals has filed a suit against Ahmedabad headquartered Cadila Healthcare at a US district court alleging that the latter would be infringing the former
NATCO Pharma plans to seek a compulsory licence from the government to make Bayer AG's Nexavar in India, invoking a provision in local laws that allows generic drugmakers to make and sell patented drugs cheaply if the medicine is unaffordable. The development, a test case for such licensing in India, …
Nearly 2 billion people (a third of the world's population) lack access to essential medicines. In low-income and middle-income countries, drugs account for 20
The Madras High Court, in a recent order, instructed industries in the SIPCOT industrial estate of Cuddalore, Tamil Nadu to pay Rs one lakh each to measure the pollution levels in the estate. At the court’s behest, the study is to be conducted by the National Environmental Engineering Research Institute …
The last 10 years were a crucial transition period for the Indian pharmaceutical industry. The next 10 years will be more crucial, predict industry experts. The period between 2000 and 2010 witnessed India
B Krishna Mohan / Hyderabad December 24, 2010, 0:59 IST A three-member committee, comprising two officials from the Director of Factories and one pharma expert, will probe the gas leak at a production unit of Dr Reddy
Indomethacin, Trimethoprim Get Approval GLENMARK Pharmaceuticals said it has received the US health regulator's approval to market three generic products in the American market. Glenmark Generics Inc, the US-based subsidiary of the company has received final approval from the US Food and Drug Administration (USFDA) for two products -- Indomethacin …
